Another study by Chen et al. had similar findings in metastatic melanoma patients, reporting that stimulation with IFN-γ increased PD-L1 in tumour-secreted exosomes and proposed that patients can be stratified into responders or non-responders to immunotherapy according to the increase in circulating PD-L1 during initial treatment with ICIs [126]. The gene discussed is IFNG; the disease is neoplasm.